When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool World Journal of Urology, 05/15/2012

De Nunzio C et al. – The study validated in a group of patients with prostate cancer (PCa) the novel risk stratification tool proposed by Briganti, which presented a higher accuracy for baseline staging bone scan when compared with the European Association of Urology guideline. In the authors' experience, this approach would further reduce the use of staging baseline bone scan without compromising the ability to detect BMs in patients with PCa.